nëo™ is the newest, now with automatic annotation of seizure activity*, most easy to use cerebral function monitor (CFM) solution available to busy NICUs. Designed to account for NICU workflows - from electrode application, to monitoring, event annotation and review. The nëo CFM easily integrates into the NICU’s neonatal brain monitoring protocols.

Features:

• Selectable from a single, 2 channel recording or up to 8 referential aEEG/EEG channels

• Automatic annotation of seizure activity* on up to 2 user-defined aEEG channels

• Easy to read Greyscale feature for aEEG

• Online graphical and numeric Burst Suppression Ratio (BSR) and Inter-Burst-Interval (IBI)

• Streamlined setup to initiate monitoring or review sessions

• Easy exporting of data and screenshots at any time

• Quick access to pre-defined and custom annotations

neo monitor is CE marked as a medical device in the EU, according to MDD 93/42/EEC, class lla and has FDA clearance under 510(k) in the USA. Medical Device License (MDL) issued by Health Canada. Compliant with the Australian TG(MD)R and registered in the ARTG. Manufactured by eemagine GmbH, Berlin, Germany, ISO 13485 certified. ANT Neuro and eemagine are part of the neuromotion group. For the regulatory status of neo monitor outside of Australia, Canada, EU and USA, please contact your local distributor or ANT representation.